Clear cell renal cell carcinoma
Conditions
Interventions
Sponsors
Fudan University Shanghai Cancer Center
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Voluntarily sign the informed consent form. 2. Age >=18 years. 3. Patients with ccRCC highly suspected or confirmed by pathology or conventional imaging. 4. Expected survival of 3 months, as judged by the physician. 5. agree to practice strict contraception for at least 28 days after PET/CT examination. 6. Willing and able to follow the study protocol.
Exclusion criteria
Exclusion criteria: Subjects will be excluded from this study if any of the following conditions are present: 1. patients diagnosed with other malignancies in the last 1 year. 2. patients diagnosed with other pathologic types of renal cell carcinoma during follow-up. 3. patients undergoing any anti-tumor therapy between two PET/CT examinations. 4. Women who are pregnant or breastfeeding. 5. Unable to cooperate with lying on the PET/CT scanning bed during the scan or intolerant to PET examination. 6. Patients who have received or are receiving treatment such as radiotherapy, chemotherapy, immunotherapy or molecular targeted therapy. 7. Participation in other interventional clinical trials within 1 month prior to screening. 8.Patients who have missed a visit. 9.Other conditions that may affect the study or make the subject unsuitable for participation in the study, as assessed by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SUVmax (Standardized Uptake Value max); | — |
Countries
China
Contacts
Public ContactShaoli Song
Fudan University Shanghai Cancer Center
Outcome results
None listed